C79.3 Secondary malignant neoplasm of brain and cerebral meninges

Name of the Condition

• Secondary Malignant Neoplasm of Brain and Cerebral Meninges (ICD-10 code: C79.3)

Summary

Secondary malignant neoplasm of brain and cerebral meninges refers to cancer that has spread to the brain and its protective membranes (meninges) from a primary tumor located elsewhere in the body. This condition is also known as metastatic disease involving the central nervous system.

Causes

The primary cause is the spread of cancer cells from the original tumor site to the brain and meninges. Common primary cancers that metastasize to these areas include lung cancer, breast cancer, melanoma, and colorectal cancer.

Risk Factors

• History of a primary cancer, especially types with a high likelihood of metastasis.
• Advanced stage of the primary cancer.
• Genetic or molecular factors that promote cancer spread.
• Weakened immune system.

Symptoms

• Headaches, often severe or persistent.
• Neurological deficits such as weakness, numbness, or difficulty with coordination.
• Cognitive changes, including memory loss or personality changes.
• Seizures.
• Vision problems or other sensory disturbances.

Diagnosis

Imaging tests like MRI or CT scans to detect lesions in the brain or meninges. Biopsy to confirm the presence of cancer cells and identify the primary tumor type. Neurological exams to assess function and identify specific deficits.

Treatment Options

• Radiation Therapy: Targets cancerous cells to reduce tumor size and alleviate symptoms.
• Chemotherapy: Systemic or intrathecal administration to control cancer spread.
• Surgery: May be used to remove accessible tumors or relieve pressure.
• Supportive Care: Manages symptoms such as pain, seizures, or swelling.

Prognosis and Follow-Up

Prognosis depends on the primary cancer type, extent of metastasis, and overall health. Regular follow-up with imaging and neurological assessments is essential to monitor for recurrence or progression.

Complications

• Increased intracranial pressure leading to headaches or neurological decline.
• Seizures or other neurological dysfunction.
• Cognitive impairment or personality changes.
• Reduced quality of life due to symptom burden.

Lifestyle & Prevention

• Maintain a healthy lifestyle to support overall health and immune function.
• Follow recommended cancer screening guidelines for early detection of primary tumors.
• Avoid known carcinogens, such as tobacco smoke, to reduce cancer risk.

When to Seek Professional Help

• Persistent or worsening headaches.
• New or worsening neurological symptoms, such as weakness, numbness, or confusion.
• Seizures or changes in consciousness.
• Unexplained weight loss or fatigue.

Tips for Medical Coders

• Code C79.3 is used when a secondary malignant neoplasm involves both the brain and cerebral meninges. Ensure documentation specifies involvement of both structures to justify this code. Verify that the primary cancer site is documented separately, as C79.3 does not include primary brain or meningeal tumors.